ReviewCureus2020

FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review.

Nida Aslam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.